RARE
Ultragenyx Pharmaceutical Inc
$23.71
+1.45% (+$0.34)
Volume
1.27M
52W High
$42.37
52W Low
$18.29
Market Cap
$2.43B
Next Earnings Report
Last Reported
May 5, 2026 Missed
Actual: -$1.54
vs. Consensus: -$1.34
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
May 5, 2026
1-Day:
+3.68%
Q1 2026
Apr 30, 2026
1-Day:
+0.32%
5-Day:
+1.30%
Q4 2025
Feb 12, 2026
1-Day:
-12.68%
5-Day:
-14.13%
Q3 2025
Nov 6, 2025
1-Day:
-1.03%
5-Day:
+7.43%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $207.0M | +25.6% | 86.0% | -55.1% | -$129.0M |
| Q3'25 | $159.9M | +14.7% | 82.5% | -106.9% | -$180.4M |
| Q2'25 | $166.5M | +13.2% | 86.2% | -64.8% | -$115.0M |
| Q1'25 | $139.3M | +28.0% | 79.4% | -102.6% | -$151.1M |
| Q4'24 | $164.9M | +29.4% | 89.8% | -74.2% | -$133.4M |
| Q3'24 | $139.5M | +42.3% | 84.9% | -94.6% | -$133.5M |
| Q2'24 | $147.0M | +35.8% | 85.5% | -79.1% | -$131.6M |
| Q1'24 | $108.8M | +8.3% | 83.9% | -151.9% | -$170.7M |
Company Information
Symbol
RARE
Company
Ultragenyx Pharmaceutical Inc
Market Cap
$2.43B